Skip to main content
SpringerLink
Log in

Pathology of Endometrial Hyperplasia and Carcinoma

  • Chapter
Uterine Cancer

  • 1299 Accesses

Abstract

Endometrial cancer forms the fifth most commonly diagnosed cancer in women worldwide and the fourth most commonly diagnosed cancer in the United States [1, 2]. On an average, 154 cases are annually received at Tata Memorial Hospital (TMH), as per TMH Based Cancer Registry (2002–2005) [3]. These occur mostly in postmenopausal women. This chapter shall focus upon pathology of endometrial hyperplasias and carcinomas, including various subtypes; diagnostic challenges involved during histopathological reporting; overcoming these challenges; insights into relevant immunohistochemistry; molecular updates and finally, formulation of a scientifically correct and clinically relevant/viable histopathology report, including diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Parazzini F, Francesci S. The epidemiology of female genital tract cancers. Int J Gynecol Cancer. 1997;7:169–81.

    Article  Google Scholar 

  2. Society AC. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:4–64.

    Article  Google Scholar 

  3. Dinshaw KA, Ganesh B. Hospital based cancer registry- annual report 2008. Mumbai: Tata Memorial Hospital. p. 1–110.

    Google Scholar 

  4. Silverberg SG, Kurman RJ. Tumors of the uterine corpus and gestational trophoblastic disease. Atlas of tumor pathology. 3rd Series. Fascicle 3. Washington, DC: Armed Forces Institute of Pathology; 1992. p. 13–4.

    Google Scholar 

  5. Zaino RJ. Interpretation of endometrial biopsies and curettings. Philadelphia: Lippincott-Raven; 1996. p. 209–12.

    Google Scholar 

  6. Ellenson LH, Ronnett BM, Soslow RA, Zaino RJ, Kurman RJ. Endometrial carcinoma. In: Kurman RJ, editor. Blaustein’s pathology of the female genital tract. 6th ed. New York: Springer; 2011. p. 394–441.

    Chapter  Google Scholar 

  7. Lehman MB, Hart WR. Simple and complex hyperplastic papillary proliferations of the endometrium: a clinicopathologic study of nine cases of apparently localized papillary lesions with fibrovascular stromal cores and epithelial metaplasia. Am J Surg Pathol. 2001;25:1347–54.

    Article  CAS  PubMed  Google Scholar 

  8. Ip PP, Irving JA, McCluggage WG, Clement PB, Young RH. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia. Am J Surg Pathol. 2013;37:167–77.

    Article  PubMed  Google Scholar 

  9. Rekhi B, Menon S, Maheshwari A. Complex papillary hyperplasia of the endometrium- an uncommon case report, including cytopathological features and diagnostic implications. Diagn Cytopathol. 2015;43:163–8. doi:10.1002/dc.23170.

  10. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15:10–7.

    Article  CAS  PubMed  Google Scholar 

  11. McCluggage WG. Malignant biphasic uterine tumors: carcinosarcomas or metaplastic carcinomas. J Clin Pathol. 2002;55:321–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Silverberg SG, DeGiorgi LS. Histopathologic analysis of preoperative radiation therapy in endometrial carcinoma. Am J Obstet Gynecol. 1974;119:698–704.

    CAS  PubMed  Google Scholar 

  13. Hunter JE, Tritz DE, Howell MG, DePriest PD, Gallion HH, Andrews SJ, et al. The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia. Gynecol Oncol. 1994;55:66–71.

    Article  CAS  PubMed  Google Scholar 

  14. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer. 1985;56:403–12.

    Article  CAS  PubMed  Google Scholar 

  15. Baak JP, Wisse-Brekelmans EC, Fleege JC, van der Putten HW, Bezemer PD. Assessment of the risk on endometrial cancer in hyperplasia, by means of morphological and morphometrical features. Pathol Res Pract. 1992;188:856–9.

    Article  CAS  PubMed  Google Scholar 

  16. Reid-Nicholson M, Iyengar P, Hummer AJ, Linkov I, Asher M, Soslow RA. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis. Mod Pathol. 2006;19:1091–100.

    CAS  PubMed  Google Scholar 

  17. Scholten AN, Creutzberg CL, van den Broek LJ, Noordijk EM, Smit VT. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. J Pathol. 2003;201:460–5.

    Article  CAS  PubMed  Google Scholar 

  18. Liao CL, Hsu JD, Lee MY, Kok LF, Li YJ, Wang PH, Yao CC, Han CP. Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough? Virchows Arch. 2010;456:377–86.

    Google Scholar 

  19. Morrison C, Merati K, Marsh Jr WL, De Lott L, Cohn DE, Young G, Frankel WL. The mucin expression profile of endometrial carcinoma and correlation with clinical-pathologic parameters. Appl Immunohistochem Mol Morphol. 2007;15:426–31.

    Article  CAS  PubMed  Google Scholar 

  20. Vang R, Barner R, Wheeler DT, Strauss BL. Immunohistochemical staining for Ki-67 and p53 helps distinguish endometrial Arias-Stella reaction from high-grade carcinoma, including clear cell carcinoma. Int J Gynecol Pathol. 2004;23:223–33.

    Article  PubMed  Google Scholar 

  21. Deodhar KK, Rekhi B, Menon S. Female genital system. Uterus and cervix. In: Desai SS, Bal M, Rekhi B, Jambhekar NA, editors. Grossing of surgical oncology specimens. Tata Memorial Hospital; Mumbai, India:2011. p. 124–31.

    Google Scholar 

  22. American Joint Committee on Cancer. Corpus uteri. In: AJCC cancer staging manual, 7th ed. New York: Springer; 2010. p. 403.

    Google Scholar 

  23. NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms. Available at: http://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf. Accessed 28 Mar 2015.

  24. Kaku T, Tsuruchi N, Tsukamoto N, Hirakawa T, Kamura T, Nakano H. Reassessment of myometrial invasion in endometrial carcinoma. Obstet Gynecol. 1994;84:979–82.

    CAS  PubMed  Google Scholar 

  25. Inoue Y, Obata K, Abe K, Ohmura G, Doh K, Yoshioka T, et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer. 1996;78:1447–51.

    Article  CAS  PubMed  Google Scholar 

  26. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller PB, Homesley HD, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group Study. Gynecol Oncol. 1991;40:55–65.

    Article  CAS  PubMed  Google Scholar 

  27. Duffy DL, Antill YC, Stewart CJ, Young JP, kConFab, Spurdle AB. Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive families. Twin Res Hum Genet. 2011;14:111–8.

    Article  PubMed  Google Scholar 

  28. Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol. 2000;13:295–308.

    Article  CAS  PubMed  Google Scholar 

  29. Salvesen HB, Das S, Akslen LA. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis. Clin Cancer Res. 2000;6:153–9.

    CAS  PubMed  Google Scholar 

  30. Rolitsky CD, Theil KS, McGaughy VR, Copeland LJ, Niemann TH. HER-2/neu amplification and overexpression in endometrial carcinoma. Int J Gynecol Pathol. 1999;18:138–43.

    Article  CAS  PubMed  Google Scholar 

  31. Morrison C, Zanagnolo V, Ramirez N, Cohn DE, Kelbick N, Copeland L, et al. HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients. J Clin Oncol. 2006;24:2376–85.

    Article  CAS  PubMed  Google Scholar 

  32. Garg K, Soslow RA. Endometrial carcinoma in women aged 40 years and younger. Arch Pathol Lab Med. 2014;138:335–42.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

I am grateful to the pathology residents of TMH, Dr. Chhavi Gupta, Dr. Aekta Dubey, and Dr. Sushant Vinarkar, who helped me in procuring gross images of specimens and in retrieving histopathology slides for microscopic images. I also thank Dr. Amita Maheshwari, Professor, Surgical Oncology (Gynaecology), for providing gross image of a case of endometrial carcinoma.

Author information

Authors and Affiliations

  1. Department of Pathology, Tata Memorial Hospital (TMH), Dr E.B. Road, Mumbai, 400012, India

    Bharat Rekhi MD, DNB, MIAC, Kedar K. Deodhar & Santosh Menon

Authors
  1. Bharat Rekhi MD, DNB, MIAC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kedar K. Deodhar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Santosh Menon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bharat Rekhi MD, DNB, MIAC .

Editor information

Editors and Affiliations

  1. Obstetrics and Gynecology, University College of Medical Sciences, New Delhi, India

    Shalini Rajaram

  2. Surgical &Gynec Oncology, Lakeshore & Welcare Hospitals, Kochi, Kerala, India

    Chitrathara K

  3. Gynec Onclogy, Tata Memorial Hospital, Mumbai, India

    Amita Maheshwari

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer India

About this chapter

Cite this chapter

Rekhi, B., Deodhar, K.K., Menon, S. (2015). Pathology of Endometrial Hyperplasia and Carcinoma. In: Rajaram, S., K, C., Maheshwari, A. (eds) Uterine Cancer. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1892-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-81-322-1892-0_10

  • Publisher Name: Springer, New Delhi

  • Print ISBN: 978-81-322-1891-3

  • Online ISBN: 978-81-322-1892-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation